LONDON — British health authorities have for the first time approved an antibody test that shows whether people have previously been exposed to the new coronavirus.
The test, manufactured by Swiss pharmaceutical firm Roche, has already been approved for use in the United States and the European Union.
Public Health England says government scientists found the test to be 100% accurate. It shows whether people have been exposed to the virus that causes COVID-19 and have developed antibodies against it, which may provide some immunity.
The British government says it is working on plans to offer antibody tests to health care workers and the public.
Prime Minister Boris Johnson has said an antibody test could be a “game changer” in allowing the U.K. to end its national lockdown. But attempts to find a reliable test have been troubled. Some 17.5 million tests ordered from various suppliers all failed to meet U.K. standards.
GENEVA (AP) — The World Health Organization said Friday that COVID-19 no longer qualifies as a global emergency, marking a symbolic end to the devastating coronavirus pandemic that triggered once-unthinkable lockdowns, upended economies and killed millions of people worldwide.
FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.
Explore articles from the past and connect to your heritage!
Discover the benefits of a subscription including access to exclusive content, events, and more!
Have an idea for a story, or know of an event we should cover? We want to hear about it!
The National Herald is the paper of record of the Greek Diaspora community. Through independent journalism, we bring news to generations of Greek-Americans, with stories on the individual, community and international level. Visit and support our 106 year-old sister publication Εθνικός Κήρυξ.
To purchase a gift subscription, please log out of your account, and purchase the subscription with a new email ID.
Sign up to receive our daily email news briefing.
Sign up for a subscription to The National Herald,
starting as low as $1/week.
and receive more access to The National Herald
View our Terms of Service + Privacy Policy.
and receive more access to The National Herald
View our Terms of Service + Privacy Policy.
We use cookies on our site to personalize your experience, bring you the most relevant content, show you the most useful ads, and to help report any issues with our site. You can update your preferences at any time by visiting preferences. By selecting Accept, you consent to our use of cookies. To learn more about how your data is used, visit our cookie policy.
$1.08 USD
